ARTICLE | Company News
Teva, Novartis deal
August 4, 2014 7:00 AM UTC
Teva granted Novartis’ Sandoz Inc. generics unit rights to market 100 and 200 mg dosage strengths of a generic version of Teva’s sleep disorder drug Nuvigil armodafinil 180 days after Actavis plc (N...